A cutting edge opportunity

Presented by

Chris Iggo - CIO, Linden Thomson - Portfolio Manager, Peter Hughes - Portfolio Manager

About this talk

Join Chris, Linden and Peter as they discuss why biotechnology is a burgeoning specialist field that is transforming the way diseases are treated. It continues to deliver on R&D pipeline progress and commercial growth despite the macro conditions impacting other, more cyclical sectors. These are the core fundamentals of the expected long-term growth in the sector, and they have arguably been strengthened further during the COVID pandemic.

Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (8)
Subscribers (121)
Welcome to AXA Investment Managers (AXA IM). We are a responsible asset manager, actively investing for the long-term to help our clients, our people and the world to prosper. Our high conviction approach enables us to uncover what we believe to be the best global investment opportunities across all major asset classes.